Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
UTC Therapeutics Inc.
Pliant Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Shanghai 10th People's Hospital
Centre Hospitalier Universitaire Vaudois
Zhejiang University
Celon Pharma SA
HRYZ Biotech Co.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Multitude Therapeutics Inc.
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Seoul National University Hospital
BGI, China
Zhongnan Hospital
Impact Therapeutics, Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Northwell Health
Revolution Medicines, Inc.
Imperial College London
Fudan University
Silverback Therapeutics
Corregene Biotechnology Co., Ltd
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
West China Second University Hospital
Peking University People's Hospital
West China Second University Hospital
Huazhong University of Science and Technology
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sun Yat-sen University
Ruijin Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Huazhong University of Science and Technology
Hebei Senlang Biotechnology Inc., Ltd.
Lee's Pharmaceutical Limited
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Ruijin Hospital
Massachusetts General Hospital
Splash Pharmaceuticals, Inc.
Lee's Pharmaceutical Limited
Hunan Cancer Hospital
Shenzhen People's Hospital
GOG Foundation
Critical Outcome Technologies Inc.
Placon Therapeutics
Jiangsu Simcere Pharmaceutical Co., Ltd.
Mie University
British Columbia Cancer Agency
Merrimack Pharmaceuticals
Oncolix, Inc.